

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb229</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Cloning and Optimization of Soluble Vascular Endothelial Growth Factor165 Expression in &lt;i&gt;Escherichia coli&lt;/i&gt;</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Salimi</surname><given-names>Ali</given-names></name></contrib><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Babashamsi</surname><given-names>Mohammad</given-names></name></contrib><aff>Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences      , Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>8</volume>
      <issue>1</issue>
      <fpage>23</fpage>
      <lpage>28</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Vascular Endothelial Growth Factor (VEGF) is a coordinate regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. There are several types of VEGF, including VEGF&lt;sub&gt;165&lt;/sub&gt;. VEGFs stimulate endothelial cell growth, angiogenesis, and capillary permeability. Low induction temperature is a major factor for expression of the recombinant VEGF&lt;sub&gt;165&lt;/sub&gt; in soluble form. The purpose of this study was cloning and optimization of soluble vascular endothelial growth factor165 expression in &lt;em&gt;Escherichia coli (E. coli)&lt;/em&gt;.&lt;br /&gt;
Methods: In this study, total RNA of HeLa cell [cervix epithelium] was extracted. The VEGF&lt;sub&gt;165&lt;/sub&gt; gene was amplified by reverse transcription polymerase chain reaction (RT-PCR), and then VEGF&lt;sub&gt;165&lt;/sub&gt; was subcloned into prokaryotic expression vectors pET-32a(+) and transformed into BL21 (DE3) &lt;em&gt;E. coli&lt;/em&gt; strain. VEGF&lt;sub&gt;165&lt;/sub&gt; expression was optimized by fine adjustments such as induction time and incubation temperature. VEGF&lt;sub&gt;165&lt;/sub&gt; was analyzed by DNA sequencing prior to expression and the protein was further characterized by SDS-PAGE and immunoblotting using His&amp;bull;tag specific polyclonal antibody.&lt;br /&gt;
Results: Our results demonstrated that VEGF&lt;sub&gt;165&lt;/sub&gt; was successfully cloned and expressed in pET-32a(+) vector. Optimization of the expression procedure showed that, induction by 1 &lt;em&gt;mM&lt;/em&gt; IPTG at OD600=0.7 and overnight incubation at 22&lt;sup&gt;o&lt;/sup&gt;&lt;em&gt;C&lt;/em&gt; resulted in the highest expression levels of soluble VEGF&lt;sub&gt;165&lt;/sub&gt;.&lt;br /&gt;
Conclusion: In this study, the expression of VEGF&lt;sub&gt;165&lt;/sub&gt; in a high soluble level was successfully cloned and optimized.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
